Deaths due to heart failure and hypertensive heart disease are increasing in the U.S. — particularly in Black women and men — despite medical and surgical advances in heart disease management, according to a new Northwestern Medicine study.
Browsing: Clinical Breakthroughs
Residents working shifts of 16 hours or less didn’t make fewer errors than residents assigned to 24-hour shifts, according to a recent study published in NEJM.
In older adults with type 1 diabetes, continuous blood glucose monitoring was more effective in reducing hypoglycemia than standard blood glucose monitoring, according to recent findings published in JAMA.
Patients with influenza at risk of complications recovered more quickly after early treatment with the drug baloxavir marboxil, according to a study published in The Lancet Infectious Diseases.
Cancer patients with other comorbidities have a higher risk of dying from complications due to COVID-19, and should discuss the risks and benefits of continuing cancer treatment with their physician, according to a recent study.
A novel drug called enzalutamide may extend overall survival for men with nonmetastatic, castration-resistant prostate cancer, according to findings from clinical trial published in The New England Journal of Medicine.
A new patient-centered decision support tool aims to help pregnant women decide whether they prefer trial-of-labor or a repeat cesarean delivery after having a prior cesarean.
A drug originally designed as cancer therapy virtually eliminated allergic reactions in moderate cases and significantly lessened the risk of death in severe cases, according to a new study in animal models.
Northwestern Medicine investigators undertook a massive, new, daily home-monitoring program of patients presumed positive for COVID-19 with the assistance of nurses, nurse practitioners, a large workforce of medical students, physicians’ assistants and daily questionnaires delivered through electronic health records.
As the COVID-19 pandemic continues, recent editorials published by Feinberg faculty explore COVID-19 and its impact on medicine, including potential drug targets and the need for more clinical trials to maximizing trainee education.